Aligomics Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
06:00
Jan 08
Jan 08
Gene therapy names may draw JPM attention
The JPMorgan Healthcare Conference trend is shifting toward gene therapy, including gene-based obesity treatments, and Lee says Korean gene therapy companies OliX Pharmaceuticals and Aligomics could receive attention.
MED
About Aligomics Investor Commentary
Across the available history and selected sources, Buzzberg tracks Aligomics across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Kwon-hee.